Research & News
New studies, trial results, publications and industry news. 40 discussions in this community. Create a free account to ask a question or share your experience.
Discussions in Research & News
- TUDCA: Liver support or just hype? - 1 points, 2 comments
- Is AICAR the New Exercise Mimetic or a Myth? - 2 points, 3 comments
- KLOW Stack: My Low‑Dose Trial and How It Actually Felt - 3 points, 4 comments
- Thoughts on the recent MK-677 oral GH secretagogue update - 6 points, 4 comments
- Thoughts on the latest tirzepatide dual agonist data - 4 points, 11 comments
- Thoughts on Pancragen peptide profile and what it means for metabolic health - 6 points, 3 comments
- Thoughts on the latest alprostadil update in the peptide database - 4 points, 4 comments
- FDA Committee Votes to Open Peptide Pathways, What Happens Next? - 5 points, 4 comments
- Recent article on TB-4 topical for hair – what do you think? - 7 points, 4 comments
- Mazdutide’s Weight‑Loss Promise – Too Good to Be True or Next Big Step? - 5 points, 5 comments
- Survodutide’s 19% Weight Loss Claim, What I Think - 6 points, 9 comments
- Klotho protein news – what the latest research says about aging and cognition - 5 points, 2 comments
- FDA Panel Nods to Compounding Peptides: What It Means for Users - 8 points, 4 comments
- Horvath’s Altos Labs claim to reverse ageing, what’s realistic? - 7 points, 4 comments
- Chinese Stem‑Cell Trial Shows Reversal of Aging Signs in Monkeys - 4 points, 4 comments
- Chinese peptides trend in silicon valley – hype or next step? - 7 points, 8 comments
- OrbiMed's $89M Boost Signals Oral Peptide Pipeline Might Take Off - 4 points, 10 comments
- FDA panel gives green light to unapproved peptides amid safety worries - 9 points, 8 comments
- FDA Tightens Grip on Compounded GLP‑1s: What That Means - 10 points, 8 comments
- Is Thymosin Beta‑4 a real game‑changer for heart recovery? - 9 points, 3 comments
- FDA steps up on compounded GLP‑1 drugs: safety first or over‑reach? - 6 points, 4 comments
- Hims & Hers Goes UK with GLP‑1 Weight‑Loss – A Mixed Blessing? - 5 points, 5 comments
- FDA May Loosen Peptide Rules, But Safety Still a Big Question - 6 points, 8 comments
- Nyt: re‑juvenating 90‑year‑old skin cells – the next big breakthrough? - 7 points, 4 comments
- FDA Considers Re‑approval of Research Peptides - 8 points, 8 comments
- SGLT2 Inhibitors: Diabetes Drug That Might Slow Aging? - 2 points, 3 comments
- Recent look at GHK‑Cu topical for hair – thoughts? - 4 points, 6 comments
- Pinnacle Medicines' $89M boost could bring oral peptide pills to market - 3 points, 6 comments
- FDA move to pull semaglutide from compounding list – what it means for us - 10 points, 4 comments
- First “reverse‑age” injection in a human – hope or hype? - 7 points, 6 comments
- Rilmenidine: A Drug That May Mimic Calorie Restriction for Longevity? - 4 points, 3 comments
- FDA pushes to let pharmacies make six “hot” peptides – what does that mean for Aussie biohackers? - 9 points, 4 comments
- New study shows senescent‑cell targeting could boost healthy ageing - 7 points, 4 comments
- FDA Declares No Clinical Need for Compounded GLP‑1 Weight Loss Drugs - 9 points, 11 comments
- UK pushes peptide production tech forward – will it really cut costs? - 8 points, 4 comments
- UK watchdog probes peptide clinics over unverified claims - 6 points, 8 comments
- Using HGH Fragment 176‑191 for Fat Loss – What the Paper Says and My Take - 7 points, 4 comments
- GLP‑1 telehealth boom sparks safety watchdog calls - 4 points, 6 comments
- Biohacking Claims for Reversing Age: Hype or Hope? - 5 points, 3 comments
- Dihexa Oral: New No‑otropic with Potential for Synaptogenesis? - 5 points, 4 comments
Related compounds
- BPC-157 - Body Protection Compound-157
- TB-500 - Thymosin Beta-4 (Synthetic)
- Pentosan Polysulfate - Pentosan Polysulfate Sodium
- KPV - Lysine-Proline-Valine Tripeptide
- Thymosin Beta-4 - Thymosin Beta-4 (Full Length)
- LL-37 - Cathelicidin Antimicrobial Peptide LL-37
- AOD-9604 - Advanced Obesity Drug Fragment 176-191 (Modified)
- Semaglutide - Semaglutide (GLP-1 Receptor Agonist)
Community discussion - research and educational context only. Not medical advice.